CLBAX | PAADX | CLBAX / PAADX | |
Total Expense Ratio | 0.60 | 0.71 | 85% |
Annual Report Gross Expense Ratio | 0.60 | 0.71 | 85% |
Fund Existence | 23 years | 13 years | - |
Gain YTD | -3.231 | -4.433 | 73% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 226B | 1.99B | 11,368% |
Annual Yield % from dividends | 1.98 | 2.93 | 68% |
Returns for 1 year | 0.90 | -3.98 | -22% |
Returns for 3 years | 11.54 | 3.78 | 306% |
Returns for 5 years | 37.11 | 21.13 | 176% |
Returns for 10 years | 57.22 | 19.29 | 297% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GEMEX | 22.30 | 0.59 | +2.72% |
GMO Emerging Markets I | |||
AWAYX | 19.55 | 0.40 | +2.09% |
AB Wealth Appreciation Strategy Advisor | |||
FGRAX | 42.75 | 0.69 | +1.64% |
Franklin Growth Opportunities A | |||
MASPX | 25.37 | 0.34 | +1.36% |
BlackRock Advantage SMID Cap Instl | |||
NESIX | 14.67 | 0.18 | +1.24% |
Needham Small Cap Growth Institutional |